SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-010381
Filing Date
2021-02-12
Accepted
2021-02-12 18:08:02
Documents
1
Period of Report
2021-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6704
  Complete submission text file 0001209191-21-010381.txt   8194
Mailing Address 132 PURDURE AVENUE KENGSINGTON CA 94708
Business Address
BJERKHOLT ERIC (Reporting) CIK: 0001197350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37345 | Film No.: 21630537

Mailing Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102 206-485-7051
CHINOOK THERAPEUTICS, INC. (Issuer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences